Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 13, 2018 - Issue
Submit an article Journal homepage
53
Views
7
CrossRef citations to date
0
Altmetric
Original Research

The distribution of blood eosinophil levels in a Japanese COPD clinical trial database and in the rest of the world

Neil Barnes1 Respiratory Medicine Franchise, GlaxoSmithKline, Brentford, UK;2 William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, London, UKCorrespondence[email protected]
,
Takeo Ishii3 Medical Affairs, GlaxoSmithKline K.K., Tokyo, Japan;4 Graduate School of Medicine, Nippon Medical School, Tokyo, Japan
,
Nobuyuki Hizawa5 Department of Pulmonary Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
,
Dawn Midwinter6 Global Respiratory Department, GlaxoSmithKline, Stockley Park, UK
,
Mark James3 Medical Affairs, GlaxoSmithKline K.K., Tokyo, Japan
,
Emma Hilton1 Respiratory Medicine Franchise, GlaxoSmithKline, Brentford, UK
&
Paul W Jones1 Respiratory Medicine Franchise, GlaxoSmithKline, Brentford, UK;7 Institute of Infection and Immunity, St George’s University of London, London, UK
 show all
Pages 433-440 | Published online: 02 Feb 2018

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Nobuyuki Hizawa, Koichi Fukunaga, Hisatoshi Sugiura, Yasutaka Nakano, Motokazu Kato, Yutaro Sugiyama, Tomohiro Hanazawa, Toshihiko Kaise, Ruth Tal-Singer, Paul W Jones, Neil Barnes, Chris Compton & Takeo Ishii. (2021) A Prospective Cohort Study to Assess Obstructive Respiratory Disease Phenotypes and Endotypes in Japan: The TRAIT Study Design. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1813-1822.
Read now

Articles from other publishers (6)

Dave Singh, Alvar AgustiFernando J. MartinezAlberto Papi, Ian D. PavordJadwiga A. WedzichaClaus F. Vogelmeier & David M. G. Halpin. (2022) Blood Eosinophils and Chronic Obstructive Pulmonary Disease: A Global Initiative for Chronic Obstructive Lung Disease Science Committee 2022 Review. American Journal of Respiratory and Critical Care Medicine 206:1, pages 17-24.
Crossref
Sumitra Shantakumar, Yu-Fan Ho, Janine Beale & Barry Gribben. (2021) Burden of illness in blood eosinophilic phenotype COPD patients in New Zealand. Respiratory Investigation 59:4, pages 487-497.
Crossref
Koichi Nishimura, Masaaki Kusunose, Ryo Sanda, Mio Mori, Ayumi Shibayama & Kazuhito Nakayasu. (2021) Is Blood Eosinophil Count a Biomarker for Chronic Obstructive Pulmonary Disease in a Real-World Clinical Setting? Predictive Property and Longitudinal Stability in Japanese Patients. Diagnostics 11:3, pages 404.
Crossref
Kyriakos Souliotis, Luís Silva Miguel, Georgios Hillas, Margarida Borges, Giannis Papageorgiou, Diogo Viana, Joao Malhadeiro & Stéphane Soulard. (2020) The cost-saving switch from inhaled corticosteroid-containing treatments to dual bronchodilation: a two-country projection of epidemiological and economic burden in chronic obstructive pulmonary disease. Therapeutic Advances in Respiratory Disease 14, pages 175346662092680.
Crossref
Hong-Xia Wu, Kai-Quan Zhuo & De-Yun Cheng. (2019) Prevalence and Baseline Clinical Characteristics of Eosinophilic Chronic Obstructive Pulmonary Disease: A Meta-Analysis and Systematic Review. Frontiers in Medicine 6.
Crossref
Tanja Fens, Simon van der Pol, Janwillem W.H. Kocks, Maarten J. Postma & Job F.M. van Boven. (2019) Economic Impact of Reducing Inappropriate Inhaled Corticosteroids Use in Patients With Chronic Obstructive Pulmonary Disease: ISPOR's Guidance on Budget Impact in Practice. Value in Health 22:10, pages 1092-1101.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.